What is Pralsetinib: Uses, Dosage, Side Effects and More

Pralsetinib is a targeted cancer medication that blocks specific proteins driving certain types of cancer growth. It's designed to treat cancers with RET gene changes, which occur when your body's normal cell growth signals get disrupted and allow cancer cells to multiply unchecked.

This medication represents a more precise approach to cancer treatment. Instead of affecting all rapidly dividing cells like traditional chemotherapy, pralsetinib specifically targets the abnormal RET protein that fuels certain cancers. This targeted approach can help slow or stop cancer growth while potentially causing fewer side effects than broader treatments.

What is Pralsetinib Used For?

Pralsetinib treats specific types of cancer that have RET gene mutations or rearrangements. Your doctor will test your cancer cells to confirm these genetic changes before prescribing this medication.

The medication is primarily used for non-small cell lung cancer (NSCLC) that has spread or cannot be removed with surgery. It's also approved for certain types of thyroid cancer, including medullary thyroid cancer and other thyroid cancers with RET changes that have not responded to radioactive iodine treatment.

Less commonly, pralsetinib may be used for other solid tumors that have RET gene alterations. Your oncologist will determine if your specific cancer type and genetic profile make you a good candidate for this treatment. The decision depends on your cancer's genetic makeup, how far it has spread, and your overall health condition.

How Does Pralsetinib Work?

Pralsetinib works by blocking the RET protein, which acts like a faulty switch in cancer cells. When RET genes are altered, they send constant "grow and divide" signals to cells, leading to uncontrolled cancer growth.

Think of RET as a gas pedal that's stuck in the pressed position. Pralsetinib acts like a brake that stops this accelerated cell division. By blocking these signals, the medication can slow tumor growth and may even shrink existing tumors.

This is considered a moderately strong targeted therapy. Unlike traditional chemotherapy that affects many types of cells, pralsetinib specifically targets cancer cells with RET alterations. This precision approach means it can be quite effective for the right patients while potentially causing fewer severe side effects than broader cancer treatments.

How Should I Take Pralsetinib?

Take pralsetinib exactly as your doctor prescribes, usually once daily at the same time each day. You can take it with or without food, but try to be consistent with your choice to maintain steady levels in your body.

Swallow the capsules whole with a full glass of water. Don't crush, chew, or open the capsules, as this can affect how the medication is absorbed. If you have trouble swallowing capsules, talk to your healthcare team about alternative approaches.

Your doctor may recommend taking pralsetinib with a light meal or snack if you experience stomach upset. Some patients find that taking it with food helps reduce nausea. However, avoid grapefruit and grapefruit juice while taking this medication, as they can interfere with how your body processes the drug.

Store your medication in its original container at room temperature, away from moisture and heat. Keep it out of reach of children and pets. Don't share your medication with others, even if they have a similar diagnosis.

How Long Should I Take Pralsetinib For?

You'll typically take pralsetinib for as long as it continues to control your cancer and you can tolerate the side effects. This could be months or years, depending on how well your cancer responds to treatment.

Your doctor will monitor your progress through regular scans and blood tests. These appointments help determine if the medication is working and if you're experiencing any concerning side effects. Based on these results, your treatment plan may be adjusted.

Never stop taking pralsetinib without discussing it with your oncologist first. Even if you feel well, the medication may still be working to control cancer growth. Stopping suddenly could allow your cancer to progress more quickly.

In some cases, your doctor may temporarily pause treatment if you develop significant side effects. This break allows your body to recover before potentially resuming treatment at the same or a lower dose.

What Are the Side Effects of Pralsetinib?

Most people taking pralsetinib experience some side effects, but many are manageable with proper care and monitoring. Your healthcare team will work with you to minimize these effects and maintain your quality of life.

Here are the most common side effects you might experience:

• Fatigue and weakness that may affect your daily activities
• Muscle and joint pain, particularly in your back and limbs
• High blood pressure that requires regular monitoring
• Constipation that can usually be managed with diet and medication
• Dry mouth and changes in taste
• Shortness of breath during physical activity
• Skin rash or dry skin conditions
• Decreased appetite and possible weight loss

These common effects often improve as your body adjusts to the medication. Your doctor can recommend strategies to help manage these symptoms effectively.

Some people may experience more serious side effects that require immediate medical attention. These rarer but significant effects include:

• Severe lung problems, including inflammation that causes persistent cough and breathing difficulties
• Liver problems marked by yellowing of skin or eyes, dark urine, or severe abdominal pain
• Heart rhythm changes that may cause dizziness or fainting
• Severe high blood pressure leading to headaches or vision changes
• Bleeding problems, especially if you notice unusual bruising or bleeding
• Severe skin reactions with blistering or peeling

Contact your healthcare provider immediately if you experience any of these serious symptoms. Early recognition and treatment of side effects can prevent more severe complications.

Who Should Not Take Pralsetinib?

Pralsetinib isn't suitable for everyone, and certain health conditions or medications may make it unsafe for you. Your doctor will carefully review your medical history before prescribing this medication.

You should not take pralsetinib if you're allergic to it or any of its ingredients. Signs of allergic reactions include hives, difficulty breathing, or swelling of your face, lips, tongue, or throat.

Several health conditions require special consideration before starting pralsetinib:

• High blood pressure that's difficult to control
• Heart rhythm problems or heart disease
• Liver disease or elevated liver enzymes
• Lung disease or breathing problems
• Bleeding disorders or taking blood-thinning medications
• Kidney problems that affect how your body processes medications

If you're pregnant or planning to become pregnant, pralsetinib can harm your developing baby. You'll need to use effective birth control during treatment and for several weeks after stopping the medication. Similarly, if you're breastfeeding, you'll need to discuss alternatives with your doctor.

Certain medications can interact with pralsetinib, potentially making it less effective or increasing side effects. Always inform your healthcare team about all medications, supplements, and herbal products you're taking.

Pralsetinib Brand Names

Pralsetinib is available under the brand name Gavreto in the United States. This is the primary commercial name you'll see on your prescription bottle and medication packaging.

When discussing your treatment with healthcare providers or insurance companies, you may hear both names used interchangeably. The generic name pralsetinib refers to the active ingredient, while Gavreto is the specific brand manufactured by the pharmaceutical company.

Currently, Gavreto is the only available brand of pralsetinib approved by the FDA. Generic versions are not yet available, which means your insurance coverage and cost may be different from other cancer medications that have generic alternatives.

Pralsetinib Alternatives

Several other targeted therapies may be options if pralsetinib isn't suitable for you or stops working effectively. The choice depends on your specific cancer type and genetic profile.

For RET-altered cancers, selpercatinib (Retevmo) is another RET inhibitor that works similarly to pralsetinib. Your oncologist might consider switching between these medications if one stops working or causes intolerable side effects.

For lung cancer patients, other targeted therapies might include:

• ALK inhibitors like alectinib or crizotinib if your cancer has ALK changes
• EGFR inhibitors such as erlotinib or osimertinib for EGFR-mutated cancers
• Immunotherapy medications like pembrolizumab or nivolumab
• Traditional chemotherapy combinations

For thyroid cancer, alternatives might include lenvatinib, sorafenib, or radioactive iodine therapy, depending on your specific situation. Your doctor will consider your cancer's genetic makeup, previous treatments, and overall health when recommending alternatives.

Is Pralsetinib Better Than Selpercatinib?

Both pralsetinib and selpercatinib are effective RET inhibitors, but they have some differences that might make one more suitable for you than the other. Neither is definitively "better" - the choice depends on your individual circumstances.

Both medications show similar effectiveness in treating RET-altered cancers. Clinical studies suggest they both can shrink tumors and control cancer growth in a significant percentage of patients. The response rates are comparable, with both drugs showing activity in previously treated and newly diagnosed patients.

The side effect profiles have some differences that might influence your doctor's choice:

• Pralsetinib may cause more muscle and joint pain
• Selpercatinib might be more likely to cause dry mouth and liver enzyme changes
• Both can cause fatigue and high blood pressure
• Individual patients may tolerate one better than the other

Your oncologist will consider factors like your other health conditions, current medications, and personal preferences when choosing between these options. Sometimes, if one medication stops working or causes problematic side effects, switching to the other RET inhibitor can be beneficial.